General Information of Drug (ID: DMK1Y6M)

Drug Name
CHR-5154
Indication
Disease Entry ICD 11 Status REF
Inflammation 1A00-CA43.1 Phase 1 [1]
Cross-matching ID
PubChem CID
53630042
TTD ID
D01VQM

References

1 ClinicalTrials.gov (NCT01934101) Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers. U.S. National Institutes of Health.